Table:
begin	end	state
1	25	cytoplasmic
26	49	transmembrane
50	54	non-cytoplasmic
55	74	transmembrane
75	94	cytoplasmic
95	116	transmembrane
117	121	non-cytoplasmic
122	144	transmembrane
145	162	cytoplasmic
163	183	transmembrane
184	194	non-cytoplasmic
195	218	transmembrane
219	245	cytoplasmic
246	269	transmembrane
270	278	non-cytoplasmic
279	298	transmembrane
299	309	cytoplasmic
310	329	transmembrane
330	335	non-cytoplasmic
336	360	transmembrane
361	379	cytoplasmic
380	405	transmembrane
406	416	non-cytoplasmic
417	443	transmembrane
444	466	cytoplasmic

Input:
>N515DRAFT_2416 FitnessBrowser__Dyella79:N515DRAFT_2416
MTIALESSPARAAAMADRLTLREKVGYGLGDAGGNVVIVLAMNFLNFFYTDVYGISPATV
GLMFLAVRIFDAFADPVMGILADHTRSRWGRYRPWQLWVALPLGVAVVLAFTVPPLQGDA
RIAWACVTYLLLSLGYTAINVPYCAMINAMTVSRREVVSCQSWRFALCGAAALLVSTALP
WLVEQWSGAGGPARGYQRGAAAMCAVAAAMFLCCFLWVRERVPLRNEAFSLRRLADGLRR
NDQLQLMLVMSFLLITILNVRGGGYLYFITYVLRGDARYASLFFGAVALAAILGALLVGP
LSRWLDTVRFYRYVNLALAAVSASMWFIPGGADAQLAWLLAMFGSGVVLGLCLPLHFSVM
AFADDYGQWKTGVRSSGMNFAFNLVFIKLAWASGAGIIALVLYLVRYQAGVAQTVTALGG
ITAIQTLIPAAIHLLLAFTLGFCRLDDATMKRVSQDLQQRHTDRPG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server